Allworth Financial LP Biolife Solutions Inc Transaction History

Allworth Financial LP

$20.2 Billion
Q2 2025

A detailed history of Allworth Financial LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Allworth Financial LP holds 79 shares of BLFS stock, worth $2,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$2,117

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 07, 2025	BUY	$20.64 - $25.27 $1,630 - $1,996	79 New	79 $1,000
Q3 2023 Oct 31, 2023	BUY	$10.81 - $22.96 $356 - $757	33 New	33 $0

Others Institutions Holding BLFS

# of Institutions

205

Shares Held

50.2M

Call Options Held

Put Options Held

Casdin Capital, LLC New York, NY

7.71M
Shares

$207 Million
23.27% of portfolio
Black Rock Inc. New York, NY

5.49M
Shares

$147 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

4.25M
Shares

$114 Million
0.06% of portfolio
Invesco Ltd. Atlanta, GA

3.58M
Shares

$96 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

2.9M
Shares

$77.6 Million
0.0% of portfolio

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.14B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account